Microporation may address aging in eye
LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, AnnMarie Hipsley, DPT, PhD, discusses microporation therapeutics and its potential role in presbyopia treatment.
Explore More Articles
Unlocking the recovery of dynamic range of focus with microporation therapeutics
Laser Scleral Microporation (LSM) is a therapy which represents the first biomechanical solution to the biomechanical problems of progressive presbyopia. The therapy is performed using the VisioLite® Ophthalmic Laser system developed by Ace Vision Group (AVG). Today, having no biomechanical option able to meet the loss of dynamic range of focus (DRoF) that occurs with progressive …
read moreScleral approaches to presbyopia moving from niche to mainstream
Among the many options for presbyopia, scleral approaches stand out for their unique attempt to tackle the roots of the problem, restoring physiological function rather than aiming for optical compensation. They had a slow takeoff and limited acceptance, but step by step, through a long path of research and technological upgrades, they continue to move …
read moreASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents AI-driven digital twin for simulation of aging eye
The Virtual Eye Simulation Analyzer is an AI-driven digital twin of the human eye designed to model aging and personalize presbyopia treatment across the lifecycle. AnnMarie Hipsley, DPT, PhD, presented a transformative concept in ophthalmic innovation: the “digital twin” of the human eye, embodied in the Virtual Eye Simulation Analyzer (VESA)—a virtual, AI-driven model capable …
read more